These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 1756519)
21. Clinicopathological and genetic characteristics in Chinese patients with lipoprotein glomerulopathy. Zhang B; Liu ZH; Zeng CH; Zheng JM; Chen HP; Li LS J Nephrol; 2008; 21(1):110-7. PubMed ID: 18264944 [TBL] [Abstract][Full Text] [Related]
22. [Blood lipid disorders in the nephrotic syndrome. Physiopathological aspects and therapeutic prospects]. Campanacci L Minerva Med; 1976 Sep; 67(46):2951-60. PubMed ID: 787832 [No Abstract] [Full Text] [Related]
23. Atypical hyperlipidemia and nephropathy associated with apolipoprotein E homozygosity. Ellis D; Orchard TJ; Lombardozzi S; Yunis EJ; McCauley J; Agostini R; Diamond JR J Am Soc Nephrol; 1995 Oct; 6(4):1170-7. PubMed ID: 8589283 [TBL] [Abstract][Full Text] [Related]
24. Molecular mechanisms of type III hyperlipoproteinemia: The contribution of the carboxy-terminal domain of ApoE can account for the dyslipidemia that is associated with the E2/E2 phenotype. Kypreos KE; Li X; van Dijk KW; Havekes LM; Zannis VI Biochemistry; 2003 Aug; 42(33):9841-53. PubMed ID: 12924933 [TBL] [Abstract][Full Text] [Related]
25. Study of hyperlipidemia in adults with nephrotic syndrome. Khanna UB; Nerurkar SV; Almeida AF; Taskar SP; Acharya VN J Postgrad Med; 1985 Jul; 31(3):140-5. PubMed ID: 4087215 [No Abstract] [Full Text] [Related]
26. [Rapidly progressing glomerulonephritis developing against a background of idiopathic nephrotic syndrome]. Monova D; Belovezhdov N; Minova V; Doĭchinov D Vutr Boles; 1988; 27(6):100-3. PubMed ID: 3247697 [TBL] [Abstract][Full Text] [Related]
27. [No effect of rituximab in pediatric case of severe nephrotic syndrome and focal segmental glomeruloslerosis accompanied by renal insufficiency]. Hyla-Klekot L; Grenda R; Pulcer B Pol Merkur Lekarski; 2008 Dec; 25(150):519-22. PubMed ID: 19205386 [TBL] [Abstract][Full Text] [Related]
32. Proteinuria, hyperlipidemia, and the kidney. Hutchison FN Miner Electrolyte Metab; 1993; 19(3):127-36. PubMed ID: 8232099 [TBL] [Abstract][Full Text] [Related]
33. Hyperlipidemia after organ transplantation. Markell MS; Friedman EA Am J Med; 1989 Nov; 87(5N):61N-67N. PubMed ID: 2486550 [TBL] [Abstract][Full Text] [Related]
34. Treatment of nephrotic hyperlipidemia with lovastatin. Elisaf M; Dardamanis M; Pappas M; Sferopoulos G; Siamopoulos KC Clin Nephrol; 1991 Jul; 36(1):50-2. PubMed ID: 1889153 [No Abstract] [Full Text] [Related]
35. Encephalopathy associated with steroid treated nephrotic syndrome. Yu EC; Wong SN; Yeung CY Int J Pediatr Nephrol; 1987; 8(3):135-46. PubMed ID: 3429137 [TBL] [Abstract][Full Text] [Related]
36. Type III hyperlipoproteinemia with xanthomas and multiple myeloma. Burnside NJ; Alberta L; Robinson-Bostom L; Bostom A J Am Acad Dermatol; 2005 Nov; 53(5 Suppl 1):S281-4. PubMed ID: 16227109 [TBL] [Abstract][Full Text] [Related]
37. [Nephrotic syndrome. A study of 71 adults]. Lacress R; Ringoir S; Lameire N; Debroe M Ned Tijdschr Geneeskd; 1971 Sep; 115(39):1590-7. PubMed ID: 5121217 [No Abstract] [Full Text] [Related]
38. [Thyroid function in a child with nephrotic syndrome evolving to renal failure (author's transl)]. Etling N; Lenoir G; Gehin-Fouque F Arch Fr Pediatr; 1980 Oct; 37(8):545-8. PubMed ID: 7447609 [TBL] [Abstract][Full Text] [Related]
39. Treatment of hyperlipidemia in nephrotic syndrome: time for a change? Olbricht CJ; Koch KM Nephron; 1992; 62(2):125-9. PubMed ID: 1436302 [No Abstract] [Full Text] [Related]
40. [Kidney diseases associated with hyperlipidemia and its treatment]. Aitio ML Duodecim; 1991; 107(16):1315-22. PubMed ID: 1365353 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]